Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections
Purpose: To assess choriocapillaris vascular density (VD) in healthy and advanced exudative age-related macular degeneration (ae-AMD) patients by new full-range optical coherence tomography angiography (OCT-A). Method: In this observational, cross-sectional study, 21 healthy and 21 ae-AMD eyes, alre...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97b93d5650fa47c186c783acb1de4383 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:97b93d5650fa47c186c783acb1de4383 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:97b93d5650fa47c186c783acb1de43832021-11-25T17:20:14ZChoriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections10.3390/diagnostics111119582075-4418https://doaj.org/article/97b93d5650fa47c186c783acb1de43832021-10-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/1958https://doaj.org/toc/2075-4418Purpose: To assess choriocapillaris vascular density (VD) in healthy and advanced exudative age-related macular degeneration (ae-AMD) patients by new full-range optical coherence tomography angiography (OCT-A). Method: In this observational, cross-sectional study, 21 healthy and 21 ae-AMD eyes, already treated with anti-VEGF, were enrolled. Angio-View retina patterns centered on fovea (6.4 × 6.4 mm) were acquired for all participants using Solix full-range OCT (Optovue Inc., Freemont, CA, USA). The main outcome was to compare choriocapillaris VD between healthy and ae-AMD eyes. Automated measurements of whole image choriocapillaris VD (%) and fovea grid-based (%) were collected for the analysis. Angio-View patterns were used to assess the flow area (mm<sup>2</sup>) of macular neovascularization (MNV) by contour flow measure algorithm. Best-corrected visual acuity (BCVA) of both groups was also used for the statistical analysis. Results: The mean age was 60.9 (±8.3) in healthy and 73.33 (±15.05) in ae-AMD eyes. The mean BCVA (ETDRS letters) was 98.47 (±1.50) in healthy and 7.04 (±5.96) in ae-AMD eyes. The Mann–Whitney test comparing choriocapillaries VD for whole and fovea healthy and ae-AMD eyes showed statistical significance (<i>p</i> < 0.0001 (t = 4.91; df = 40) and <i>p</i> < 0.0001 (t = 6.84; df = 40), respectively). Regarding, the correlation between MNV and VD of choriocapillaries, neither whole nor fovea areas were statistically significant (F = 0.38 (R<sup>2</sup> = 0.01) and 1.68 (R<sup>2</sup> = 0.08), respectively). Conclusions: Choriocapillaris VD showed a statistically significant reduction in comparison to healthy eyes in ae-AMD eyes. Choriocapillaris impairment can be seen in the early phase of MNV pathogenesis.Maria Cristina SavastanoClara RizzoGloria GambiniAlfonso SavastanoBenedetto FalsiniDaniela BacheriniCarmela Grazia CaputoRaphael KilianFrancesco FaraldiUmberto De VicoStanislao RizzoMDPI AGarticleadvanced exudative AMDage-related macular degenerationinnovative biotechnologiesmacular neovascularizationOCT angiographypersonalized medicineMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 1958, p 1958 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
advanced exudative AMD age-related macular degeneration innovative biotechnologies macular neovascularization OCT angiography personalized medicine Medicine (General) R5-920 |
spellingShingle |
advanced exudative AMD age-related macular degeneration innovative biotechnologies macular neovascularization OCT angiography personalized medicine Medicine (General) R5-920 Maria Cristina Savastano Clara Rizzo Gloria Gambini Alfonso Savastano Benedetto Falsini Daniela Bacherini Carmela Grazia Caputo Raphael Kilian Francesco Faraldi Umberto De Vico Stanislao Rizzo Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections |
description |
Purpose: To assess choriocapillaris vascular density (VD) in healthy and advanced exudative age-related macular degeneration (ae-AMD) patients by new full-range optical coherence tomography angiography (OCT-A). Method: In this observational, cross-sectional study, 21 healthy and 21 ae-AMD eyes, already treated with anti-VEGF, were enrolled. Angio-View retina patterns centered on fovea (6.4 × 6.4 mm) were acquired for all participants using Solix full-range OCT (Optovue Inc., Freemont, CA, USA). The main outcome was to compare choriocapillaris VD between healthy and ae-AMD eyes. Automated measurements of whole image choriocapillaris VD (%) and fovea grid-based (%) were collected for the analysis. Angio-View patterns were used to assess the flow area (mm<sup>2</sup>) of macular neovascularization (MNV) by contour flow measure algorithm. Best-corrected visual acuity (BCVA) of both groups was also used for the statistical analysis. Results: The mean age was 60.9 (±8.3) in healthy and 73.33 (±15.05) in ae-AMD eyes. The mean BCVA (ETDRS letters) was 98.47 (±1.50) in healthy and 7.04 (±5.96) in ae-AMD eyes. The Mann–Whitney test comparing choriocapillaries VD for whole and fovea healthy and ae-AMD eyes showed statistical significance (<i>p</i> < 0.0001 (t = 4.91; df = 40) and <i>p</i> < 0.0001 (t = 6.84; df = 40), respectively). Regarding, the correlation between MNV and VD of choriocapillaries, neither whole nor fovea areas were statistically significant (F = 0.38 (R<sup>2</sup> = 0.01) and 1.68 (R<sup>2</sup> = 0.08), respectively). Conclusions: Choriocapillaris VD showed a statistically significant reduction in comparison to healthy eyes in ae-AMD eyes. Choriocapillaris impairment can be seen in the early phase of MNV pathogenesis. |
format |
article |
author |
Maria Cristina Savastano Clara Rizzo Gloria Gambini Alfonso Savastano Benedetto Falsini Daniela Bacherini Carmela Grazia Caputo Raphael Kilian Francesco Faraldi Umberto De Vico Stanislao Rizzo |
author_facet |
Maria Cristina Savastano Clara Rizzo Gloria Gambini Alfonso Savastano Benedetto Falsini Daniela Bacherini Carmela Grazia Caputo Raphael Kilian Francesco Faraldi Umberto De Vico Stanislao Rizzo |
author_sort |
Maria Cristina Savastano |
title |
Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections |
title_short |
Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections |
title_full |
Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections |
title_fullStr |
Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections |
title_full_unstemmed |
Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections |
title_sort |
choriocapillaris vascular density changes: healthy vs. advanced exudative age-related macular degeneration previously treated with multiple anti-vegf intravitreal injections |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/97b93d5650fa47c186c783acb1de4383 |
work_keys_str_mv |
AT mariacristinasavastano choriocapillarisvasculardensitychangeshealthyvsadvancedexudativeagerelatedmaculardegenerationpreviouslytreatedwithmultipleantivegfintravitrealinjections AT clararizzo choriocapillarisvasculardensitychangeshealthyvsadvancedexudativeagerelatedmaculardegenerationpreviouslytreatedwithmultipleantivegfintravitrealinjections AT gloriagambini choriocapillarisvasculardensitychangeshealthyvsadvancedexudativeagerelatedmaculardegenerationpreviouslytreatedwithmultipleantivegfintravitrealinjections AT alfonsosavastano choriocapillarisvasculardensitychangeshealthyvsadvancedexudativeagerelatedmaculardegenerationpreviouslytreatedwithmultipleantivegfintravitrealinjections AT benedettofalsini choriocapillarisvasculardensitychangeshealthyvsadvancedexudativeagerelatedmaculardegenerationpreviouslytreatedwithmultipleantivegfintravitrealinjections AT danielabacherini choriocapillarisvasculardensitychangeshealthyvsadvancedexudativeagerelatedmaculardegenerationpreviouslytreatedwithmultipleantivegfintravitrealinjections AT carmelagraziacaputo choriocapillarisvasculardensitychangeshealthyvsadvancedexudativeagerelatedmaculardegenerationpreviouslytreatedwithmultipleantivegfintravitrealinjections AT raphaelkilian choriocapillarisvasculardensitychangeshealthyvsadvancedexudativeagerelatedmaculardegenerationpreviouslytreatedwithmultipleantivegfintravitrealinjections AT francescofaraldi choriocapillarisvasculardensitychangeshealthyvsadvancedexudativeagerelatedmaculardegenerationpreviouslytreatedwithmultipleantivegfintravitrealinjections AT umbertodevico choriocapillarisvasculardensitychangeshealthyvsadvancedexudativeagerelatedmaculardegenerationpreviouslytreatedwithmultipleantivegfintravitrealinjections AT stanislaorizzo choriocapillarisvasculardensitychangeshealthyvsadvancedexudativeagerelatedmaculardegenerationpreviouslytreatedwithmultipleantivegfintravitrealinjections |
_version_ |
1718412485734694912 |